Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retroperitoneal sarcomas]

A Martín-Marquina Aspiunza1, G Sanz Pérez, F Díez-Caballero Alonso

  • 1Servicio de Urología, Facultad de Medicina, Universidad de Navarra.

Actas Urologicas Espanolas
|March 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of surgical approaches to radical prostatectomy in our series beyond oncological and functional outcomes.

Actas urologicas espanolas·2022
Same author

Surgical thromboprophylaxis in daily urologic surgery: Beyond bridge therapy.

Actas urologicas espanolas·2019
Same author

Xenograft iterposition in female urethral diverticulum surgery.

Archivos espanoles de urologia·2012
Same author

[Primitive neuroectodermal tumour of the kidney. A case report].

Anales del sistema sanitario de Navarra·2012
Same author

[Lung cancer metastasizing to the prostate: case report and literature review].

Actas urologicas espanolas·2010
Same author

[Response and progression-free survival in T2 to T4 bladder tumors treated with trimodality therapy with bladder preservation].

Actas urologicas espanolas·2010
Same journal

Comparative outcomes of Mini-PCNL and suction-assisted flexible ureteroscopy in patients with renal stones ≥2 cm.

Actas urologicas espanolas·2026
Same journal

Morphometric changes in pelvic floor structure following non-invasive rehabilitation and neuromodulation assessed by ultrasound imaging.

Actas urologicas espanolas·2026
Same journal

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same journal

i-PCNL: a novel ureteral-catheter application for continuous unidirectional high-flow irrigation during Percutaneous Nephrolithotomy. Technique description and preliminary outcomes.

Actas urologicas espanolas·2026
Same journal

Reconstructing the reconstructed: Outcomes of redo-urethroplasty for recurrent urethral strictures.

Actas urologicas espanolas·2026
Same journal

Functional outcomes of pyeloplasty in children with reduced preoperative renal function: A multicenter study.

Actas urologicas espanolas·2026
See all related articles

This study on retroperitoneal sarcoma found that while surgery is primary, recurrence is common. Multimodal treatments like chemotherapy and radiotherapy may improve outcomes for these rare tumors.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiology

Context:

  • Retroperitoneal sarcomas are rare and challenging malignancies.
  • Early diagnosis is often delayed, impacting treatment outcomes.
  • Computed Tomography (CT) is the primary diagnostic imaging modality.

Purpose:

  • To present outcomes of 11 retroperitoneal sarcoma cases.
  • To evaluate the role of surgery, chemotherapy, and radiotherapy in managing these tumors.
  • To analyze factors influencing patient survival.

Summary:

  • Eleven patients with retroperitoneal sarcoma underwent surgical resection (complete or partial).
  • High recurrence rates were observed, necessitating repeat surgical interventions.
  • Adjuvant chemotherapy and radiotherapy were employed in several cases, with a 5-year survival rate of 68%.

Related Experiment Videos

Impact:

  • Highlights the aggressive nature of retroperitoneal sarcomas and frequent relapses.
  • Underscores the importance of multimodal treatment strategies.
  • Provides insights into survival rates for this patient cohort.